94 related articles for article (PubMed ID: 7982269)
41. Protective effect of chlorpromazine against the lethality of interleukin 1 in adrenalectomized or actinomycin D-sensitized mice.
Bertini R; Bianchi M; Mengozzi M; Ghezzi P
Biochem Biophys Res Commun; 1989 Dec; 165(3):942-6. PubMed ID: 2692568
[TBL] [Abstract][Full Text] [Related]
42. Protection by alpha 1-acid glycoprotein against tumor necrosis factor-induced lethality.
Libert C; Brouckaert P; Fiers W
J Exp Med; 1994 Oct; 180(4):1571-5. PubMed ID: 7931089
[TBL] [Abstract][Full Text] [Related]
43. Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model.
Barton BE; Jackson JV
Infect Immun; 1993 Apr; 61(4):1496-9. PubMed ID: 8454355
[TBL] [Abstract][Full Text] [Related]
44. Neuroendocrine regulation of in vivo cytokine production and effects: I. In vivo regulatory networks involving the neuroendocrine system, interleukin-1 and tumor necrosis factor-alpha.
Butler LD; Layman NK; Riedl PE; Cain RL; Shellhaas J; Evans GF; Zuckerman SH
J Neuroimmunol; 1989 Sep; 24(1-2):143-53. PubMed ID: 2681261
[TBL] [Abstract][Full Text] [Related]
45. Neuro-hormonal host defence in endotoxin shock.
Ramachandra RN; Sehon AH; Berczi I
Brain Behav Immun; 1992 Jun; 6(2):157-69. PubMed ID: 1504369
[TBL] [Abstract][Full Text] [Related]
46. Hypophysectomy, high tumor necrosis factor levels, and hemoglobinemia in lethal endotoxemic shock.
Bloom O; Wang H; Ivanova S; Vishnubhakat JM; Ombrellino M; Tracey KJ
Shock; 1998 Dec; 10(6):395-400. PubMed ID: 9872677
[TBL] [Abstract][Full Text] [Related]
47. Endogenous and exogenous glucocorticoids in experimental enterococcal infection.
Papasian CJ; Qureshi N; Morrison DC
Clin Vaccine Immunol; 2006 Mar; 13(3):349-55. PubMed ID: 16522776
[TBL] [Abstract][Full Text] [Related]
48. A glucocorticoid receptor-independent mechanism for neurosteroid inhibition of tumor necrosis factor production.
Di Santo E; Sironi M; Mennini T; Zinetti M; Savoldi G; Di Lorenzo D; Ghezzi P
Eur J Pharmacol; 1996 Mar; 299(1-3):179-86. PubMed ID: 8901021
[TBL] [Abstract][Full Text] [Related]
49. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor.
Bertini R; Bianchi M; Ghezzi P
J Exp Med; 1988 May; 167(5):1708-12. PubMed ID: 3259257
[TBL] [Abstract][Full Text] [Related]
50. Modulation of tumor necrosis factor activities by a potential anticachexia compound, hydrazine sulfate.
Hughes TK; Cadet P; Larned CS
Int J Immunopharmacol; 1989; 11(5):501-7. PubMed ID: 2807626
[TBL] [Abstract][Full Text] [Related]
51. [Mechanism of increasing the effect of antineoplastic agents by hydrazine sulfate].
Tret'iakov AV; Filov VA
Vopr Onkol; 1977; 23(5):94-8. PubMed ID: 407720
[TBL] [Abstract][Full Text] [Related]
52. Movement-evoked hyperalgesia induced by lipopolysaccharides is not suppressed by glucocorticoids.
Kovács KJ; Papic JC; Larson AA
Pain; 2008 May; 136(1-2):75-84. PubMed ID: 17686584
[TBL] [Abstract][Full Text] [Related]
53. [Molecular mechanism of the effect of hydrazine sulfate on various experimental neoplasms].
Burova TM; Seĭts IF
Vopr Onkol; 1981; 27(11):56-9. PubMed ID: 7336670
[No Abstract] [Full Text] [Related]
54. Mechanisms to induce tolerance by synthetic monosaccharide lipid A analogues against LPS lethality in mice.
Matsuura M; Nakano M
Prog Clin Biol Res; 1995; 392():539-48. PubMed ID: 8524962
[No Abstract] [Full Text] [Related]
55. [Gluconeogenesis during therapy of experimental tumors with hydrazine sulfate].
Filov VA; Burova TM
Biull Eksp Biol Med; 1984 Jan; 97(1):73-4. PubMed ID: 6692028
[TBL] [Abstract][Full Text] [Related]
56. The influence of a novel glucocorticoid antagonist on endotoxin lethality in mice strains.
Lazar G; Agarwal MK
Biochem Med Metab Biol; 1986 Aug; 36(1):70-4. PubMed ID: 3741703
[TBL] [Abstract][Full Text] [Related]
57. Comparative activity of human and murine tumor necrosis factor in toxicity and anti-infectious assays in mice.
Parant F; Tavernier J; Fiers W; Parant M
Microb Pathog; 1990 Feb; 8(2):143-9. PubMed ID: 2348779
[TBL] [Abstract][Full Text] [Related]
58. [Pharmacokinetics of hydrazine sulfate in intact and tumor-bearing rats].
Filov VA; Popov BV; Bezel' VS
Farmakol Toksikol; 1982; 45(4):78-81. PubMed ID: 7128794
[TBL] [Abstract][Full Text] [Related]
59. [Acetylation in mice during administration of thiophosphamide and hydrazine sulfate].
Bulovskaia LN; Kolosov AI
Vopr Onkol; 1976; 22(6):94-5. PubMed ID: 969352
[No Abstract] [Full Text] [Related]
60. Profiles of protein biosynthesis (INH) and hydrazine sulfate (HS) treated mice.
D'Souza RA; Bhide SV
Indian J Cancer; 1975 Dec; 12(4):439-45. PubMed ID: 1221048
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
